Upregulation of heme oxygenase‐1 inhibits the maturation and mineralization of osteoblasts
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Heme‐oxygenase‐1 (HO‐1), an important enzyme involved in vascular disease, transplantation, and inflammation, catalyzes the degradation of heme into carbon monoxide and biliverdin. It has been reported that overexpression of HO‐1 inhibits osteoclastogenesis. However, the effect of HO‐1 on osteoblast differentiation is still not clear. We here used adenoviral vector expressing recombinant human HO‐1 and HO‐1 inducer hemin to study the effects of HO‐1 in primary cultured osteoblasts. The results showed that induction of HO‐1 inhibited the maturation of osteoblasts including mineralized bone nodule formation, alkaline phosphatase activity and decreased mRNA expression of several differentiation markers such as alkaline phosphatase, osteocalcin, and RUNX2. Furthermore, downstream products of HO‐1, bilirubin, carbon monoxide, and iron, are involved in the inhibitory action of HO‐1. HO‐1 can be induced by H 2 O 2, lipopolysaccharide and inflammatory cytokines such as TNF‐α and IL‐1β in osteoblasts and also in STZ‐induced diabetic mice. In addition, endogenous PPARγ ligand, 15‐deoxy‐Δ 12,14‐prostaglandin‐J2 (15d‐PGJ2) markedly increased both mRNA and protein levels of HO‐1 in osteoblasts via PI3K‐Akt and MAPK pathways. Blockade of HO activity by ZnPP IX antagonized the inhibitory action on osteocalcin expression by hemin and 15d‐PGJ2. Our results indicate that upregulation of HO‐1 inhibits the maturation of osteoblasts and HO‐1 may be involved in oxidative‐ or inflammation‐induced bone loss. J. Cell. Physiol. 222: 757–768, 2010. © 2009 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heme oxygenase: Function, multiplicity, regulatory mechanisms, and clinical applications
Maines, M. D. (1988) · The FASEB Journal · doi:10.1096/fasebj.2.10.3290025 · Cited by 1,707 · cited 1×
“DOI: 10.1002/jcp.22008 Heme-oxygenase (HO) catalyzes the degradation of heme into carbon monoxide (CO), iron, and biliverdin in mammalian cells (Maines, 1988; Ryter et al., 2006).”
BackgroundInfluentialGrassi, F., Tell, G., Robbie-Ryan, M., Gao, Y., Terauchi, M., Yang, X., Romanello, M., Jones, D. P., Weitzmann, M. N., & Pacifici, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703610104 · Cited by 150 · cited 1×
“Almeida et al. (2007) demonstrated that increase of ROS is involved in age-related bone loss including decreased bone formation rate and deprivation of sex steroid by gonadectomy or ovariectomy accelerates the age-related bone loss (Almeida et al., 2007; Grassi et al., 2007).”
Background
Cited by
Heme oxygenase-1 in tumor biology and therapy
Was, H., Dulak, J., & Jozkowicz, A. (2010) · Current Drug Targets · doi:10.2174/1389450111009011551 · Cited by 259
Emerging Role of Extracellular Vesicles in Bone Remodeling
Liu, M., Sun, Y., & Zhang, Q. (2018) · Journal of Dental Research · doi:10.1177/0022034518764411 · Cited by 142
“Hmox1 is sensitive to oxidative stress and promotes osteoblastic differentiation of BMSCs (Lin et al. 2010).”
BackgroundRuiz-Gaspà, S., Martinez-Ferrer, A., Guañabens, N., Dubreuil, M., Peris, P., Enjuanes, A., de Osaba, M. J. M., Alvarez, L., Monegal, A., Combalia, A., et al. (2010) · Hepatology · doi:10.1002/hep.24605 · Cited by 75
“This result is in contrast with other experiments performed in primary rat osteoblasts, indicating that very low bilirubin concentrations (3 and 30 lM) down-regulated the expression of osteocalcin and RUNX2 in osteoblasts cultured in osteogenic medium for 3 to 14 days.(22) The OPG/RANKL system is the key regulator of…”
Result
Metadata
- Authors
- Lin, T., Tang, C., Hung, S., Liu, S., Lin, Y., Fu, W., & Yang, R.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2009-12-17
- Volume
- 222
- Issue
- 3
- Pages
- 757-768
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2164395641
- Cited by
- 66
- References
- 2
- FWCI
- 1.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.